Programme Overview

This clinician-led programme combines prescription-based Mounjaro therapy with supportive Weight-Loss Support IV infusions to help maintain metabolic balance and treatment effectiveness as dosage increases.

Treatment Purpose

The 5mg progression phase helps maintain therapeutic impact while the body adapts to treatment, supporting continued metabolic response and weight-management progress.